...
首页> 外文期刊>Natural product communications >Anti-Vancomycin-resistant Enterococcus faecium and E. faecalis Activities of (-)-Gossypol and Derivatives from Thespesia garckeana
【24h】

Anti-Vancomycin-resistant Enterococcus faecium and E. faecalis Activities of (-)-Gossypol and Derivatives from Thespesia garckeana

机译:(-)-棉酚及其衍生物的抗万古霉素肠球菌和粪肠球菌的活性

获取原文
获取原文并翻译 | 示例

摘要

The root extract of Thespesia garckeana yielded three known oxidatively coupled sesquiterpenoids, namely (-)-gossypol (1) and two of its derivatives (-)-6-methoxygossypol (2) and (+)-6,6'-dimethoxygossypol (3), and the stem bark afforded (E)-docosy1-3-(3,4-dihydroxyphenyl) acrylate (4), stigmasterol (5) and betulinic acid (6). The structures of the isolated compounds were determined on the basis of full spectral data (1D and 2D NMR and HRMS) and comparison with literature values. Compound 1 showed potent antibacterial activity against vancomycin-resistant Enterococcus faecium (VRE) with IC50/MIC/MBC values of 1.71/4.82/19.31 mu M, respectively, whereas the reference standard vancomycin was found to be inactive. The mono- and di-methoxylated derivatives of this compound, (-)-6-methoxygossypol (2) and (+)-6,6'-dimethoxygossypol (3), were less active with respective IC50/MIC/MBC values of 2.73/4.70/9.40 mu M and 6.14/18.32/18.32 mu M against this microbe. Compound 2 was more potent than 1 against the low level VRE strain with IC50/MIC/MBC values of 4.34/9.40/9.40 mu M (vs 5.23/19.31/19.31 mu M for 1). This compound also showed interesting activities against Candida glabrata with an IC50 value of 2.97 mu M, but was less active against methicillin-resistant S. aureus (MRSA) exhibiting an IC50 value of 17.33 mu M. Compound 1 demonstrated modest activity against the other microbes tested including C. glabrata, S. aureus and MRSA with IC50 values of 0.73, 9.15 and 8.99 mu M, respectively.
机译:Thespesia garckeana的根提取物产生了三种已知的氧化偶联倍半萜类化合物,即(-)-棉酚(1)及其衍生物(-)-6-甲氧基棉酚(2)和(+)-6,6'-二甲氧基棉酚(3)中的两种),茎皮得到(E)-docosy1-3-(3,4-二羟基苯基)丙烯酸酯(4),豆甾醇(5)和桦木酸(6)。在全光谱数据(1D和2D NMR和HRMS)的基础上确定分离的化合物的结构,并与文献值进行比较。化合物1对耐万古霉素的粪便肠球菌(VRE)表现出有效的抗菌活性,IC50 / MIC / MBC值分别为1.71 / 4.82 / 19.31μM,而参考标准万古霉素则无活性。该化合物的单-和二甲氧基化衍生物(-)-6-甲氧基棉酚(2)和(+)-6,6'-二甲氧基棉酚(3)的活性较低,各自的IC50 / MIC / MBC值为2.73 /4.70/9.40μM和6.14 / 18.32 / 18.32μM对付此微生物。化合物2对低水平VRE菌株的效价比1强,IC50 / MIC / MBC值为4.34 / 9.40 / 9.40μM(1则为5.23 / 19.31 / 19.31μM)。该化合物还显示出对光滑念珠菌的有趣活性,IC50值为2.97μM,但对耐甲氧西林的金黄色葡萄球菌(MRSA)的活性较低,IC50值为17.33μM。化​​合物1对其他微生物的活性中等测试的对象包括光滑念珠菌,金黄色葡萄球菌和MRSA,IC50值分别为0.73、9.15和8.99μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号